Personalized medicine can, by integrating genetic profiling, biomarkers and patient-specific data, refine the nutritional guidelines and medication regimens for preventing the development of diabetes; it can also identify individuals who are at great risk due to genetic factors, differences in insulin sensitivity or distinct metabolic reactions to specific dietary components [145,147]. Here, INS is linked to diabetes mellitus.